10 E702
Pill imprint 10 E702 has been identified as Oxycodone hydrochloride extended release 10 mg.
Oxycodone is used in the treatment of pain and belongs to the drug class narcotic analgesics. FDA has not classified the drug for risk during pregnancy.
Oxycodone 10 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.
Oxycodone hydrochloride extended release Images
- Imprint:
-
10
E702 - Strength:
- 10 mg
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- ammonio methacrylate copolymer
silicon dioxide colloidal
hydroxypropyl methylcellulose
magnesium hydroxide
magnesium stearate
microcrystalline cellulose
povidone
sodium lauryl sulfate
stearic acid
titanium dioxide
polyethylene glycol
polysorbate 80
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Endo Pharmaceuticals Inc.
- National Drug Code (NDC):
- 60951-0702
Advertisement
More Oxycodone Hydrochloride Extended Release resources
- Oxycodone
- Oxycodone (Wolters Kluwer)
- Oxycodone Concentrate (Wolters Kluwer)
- Oxycodone Solution (Wolters Kluwer)
- Oxycodone Sustained-Release Tablets (Wolters Kluwer)
- oxycodone (Cerner Multum)
- Oxy IR (Micromedex) - Includes Dosage Information
- Oxycontin CR (Micromedex) - Includes Dosage Information
- oxycodone (Micromedex) - Includes Dosage Information
- Oxycodone (AHFS DI)
- Oxycodone Hydrochloride (AHFS DI)
- Oxycodone (FDA)
- Oxycodone Capsules (FDA)
- Oxycodone ER (FDA)
- Oxycodone Extended-Release Tablets (FDA)
- Oxycodone Immediate-Release Capsules (FDA)
- Oxycodone Solution (FDA)
- Oxycodone Solution Concentrate (FDA)
- Oxycodone Hydrochloride (Wolters Kluwer)
Search Again
